BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Novartis AG 

Lichtstrasse 35

Basel    CH-4056  Switzerland
Phone: 41-0-61-3241111 Fax: 41-0-61-3248001


SEARCH JOBS




Industry
Services






 Company News
Dr. Reddy's Laboratories Ltd. (RDY) Closes The Acquisition Of Habitrol® Brand From Novartis AG (NVS) 12/19/2014 11:02:41 AM
Vernalis PLC (VNLPY.PK) Stumbles As Novartis AG (NVS) Abandons Work On AUY922 12/19/2014 6:40:00 AM
Novartis AG (NVS) Takes Stake In Israeli Biopharma BioLine; Makes $10 Million Investment 12/16/2014 7:05:34 AM
Novartis AG (NVS) Gains FDA Approval For Signifor® LAR To Treat Patients With Acromegaly, A Rare And Life-Threatening Hormonal Disorder 12/16/2014 6:11:37 AM
FDA Approves Novartis AG (NVS) Drug For Rare Hormonal Disorder 12/16/2014 6:08:32 AM
Novartis AG (NVS)-Backed Startup Annexon Bioscience Nabs $34 Million Series A 12/15/2014 7:11:33 AM
Novartis AG (NVS) Psoriasis Drug Tops Johnson & Johnson (JNJ)'s Stelara In Late-Stage Study 12/12/2014 6:24:09 AM
Novartis AG (NVS) Announces Phase 3 Layoffs At Diovan Plant In New York 12/11/2014 6:00:08 AM
Novartis AG (NVS) Release: Six-Year Pivotal Study Data Reinforce The Superiority Of Tasigna Over Gleevec In Newly-Diagnosed Patients With Ph+ CML 12/9/2014 7:05:01 AM
Novartis AG (NVS) Highlights New CTL019 Clinical Data Showing Complete Remissions In Children And Young Adults With Relapsed/Refractory Acute Lymphoblastic Leukemia 12/8/2014 7:34:33 AM
12345678910...